Clinical Trial Update: A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014) [Phase 2]

View source ↗

Summary

A Phase 2 study of Tulisokibart (MK-7240) for rheumatoid arthritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tulisokibart

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: RECRUITING